The global market for Pet Meds and Supplements was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pet Meds and Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Meds and Supplements.
The Pet Meds and Supplements market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Meds and Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Meds and Supplements manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boehringer Ingelheim
Ceva Sante Animale
Bimeda Animal Health
Dechra Pharmaceuticals
Zoetis
Merck
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences
Ambrx
Entest Biomedical
Taconic Biosciences
Dechra Veterinary Products
Ouro Fino Saude
Norbrook
Frontline
Zesty Paws
Segment by Type
External Use
Oral Use
Segment by Application
Dogs
Cats
Rabbit
Bird
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Meds and Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Meds and Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Pet Meds and Supplements Market Overview
1.1 Product Definition
1.2 Pet Meds and Supplements by Type
1.2.1 Global Pet Meds and Supplements Market Value Comparison by Type (2024 VS 2031)
1.2.2 External Use
1.2.3 Oral Use
1.3 Pet Meds and Supplements by Application
1.3.1 Global Pet Meds and Supplements Market Value by Application (2024 VS 2031)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Rabbit
1.3.5 Bird
1.3.6 Others
1.4 Global Pet Meds and Supplements Market Size Estimates and Forecasts
1.4.1 Global Pet Meds and Supplements Revenue 2020-2031
1.4.2 Global Pet Meds and Supplements Sales 2020-2031
1.4.3 Global Pet Meds and Supplements Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pet Meds and Supplements Market Competition by Manufacturers
2.1 Global Pet Meds and Supplements Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pet Meds and Supplements Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pet Meds and Supplements Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pet Meds and Supplements, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet Meds and Supplements, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Meds and Supplements, Product Type & Application
2.7 Global Key Manufacturers of Pet Meds and Supplements, Date of Enter into This Industry
2.8 Global Pet Meds and Supplements Market Competitive Situation and Trends
2.8.1 Global Pet Meds and Supplements Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pet Meds and Supplements Players Market Share by Revenue
2.8.3 Global Pet Meds and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pet Meds and Supplements Market Scenario by Region
3.1 Global Pet Meds and Supplements Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pet Meds and Supplements Sales by Region: 2020-2031
3.2.1 Global Pet Meds and Supplements Sales by Region: 2020-2025
3.2.2 Global Pet Meds and Supplements Sales by Region: 2026-2031
3.3 Global Pet Meds and Supplements Revenue by Region: 2020-2031
3.3.1 Global Pet Meds and Supplements Revenue by Region: 2020-2025
3.3.2 Global Pet Meds and Supplements Revenue by Region: 2026-2031
3.4 North America Pet Meds and Supplements Market Facts & Figures by Country
3.4.1 North America Pet Meds and Supplements Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pet Meds and Supplements Sales by Country (2020-2031)
3.4.3 North America Pet Meds and Supplements Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pet Meds and Supplements Market Facts & Figures by Country
3.5.1 Europe Pet Meds and Supplements Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pet Meds and Supplements Sales by Country (2020-2031)
3.5.3 Europe Pet Meds and Supplements Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Meds and Supplements Market Facts & Figures by Region
3.6.1 Asia Pacific Pet Meds and Supplements Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pet Meds and Supplements Sales by Region (2020-2031)
3.6.3 Asia Pacific Pet Meds and Supplements Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pet Meds and Supplements Market Facts & Figures by Country
3.7.1 Latin America Pet Meds and Supplements Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pet Meds and Supplements Sales by Country (2020-2031)
3.7.3 Latin America Pet Meds and Supplements Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Meds and Supplements Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Meds and Supplements Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pet Meds and Supplements Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pet Meds and Supplements Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pet Meds and Supplements Sales by Type (2020-2031)
4.1.1 Global Pet Meds and Supplements Sales by Type (2020-2025)
4.1.2 Global Pet Meds and Supplements Sales by Type (2026-2031)
4.1.3 Global Pet Meds and Supplements Sales Market Share by Type (2020-2031)
4.2 Global Pet Meds and Supplements Revenue by Type (2020-2031)
4.2.1 Global Pet Meds and Supplements Revenue by Type (2020-2025)
4.2.2 Global Pet Meds and Supplements Revenue by Type (2026-2031)
4.2.3 Global Pet Meds and Supplements Revenue Market Share by Type (2020-2031)
4.3 Global Pet Meds and Supplements Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pet Meds and Supplements Sales by Application (2020-2031)
5.1.1 Global Pet Meds and Supplements Sales by Application (2020-2025)
5.1.2 Global Pet Meds and Supplements Sales by Application (2026-2031)
5.1.3 Global Pet Meds and Supplements Sales Market Share by Application (2020-2031)
5.2 Global Pet Meds and Supplements Revenue by Application (2020-2031)
5.2.1 Global Pet Meds and Supplements Revenue by Application (2020-2025)
5.2.2 Global Pet Meds and Supplements Revenue by Application (2026-2031)
5.2.3 Global Pet Meds and Supplements Revenue Market Share by Application (2020-2031)
5.3 Global Pet Meds and Supplements Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Pet Meds and Supplements Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Ceva Sante Animale
6.2.1 Ceva Sante Animale Company Information
6.2.2 Ceva Sante Animale Description and Business Overview
6.2.3 Ceva Sante Animale Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ceva Sante Animale Pet Meds and Supplements Product Portfolio
6.2.5 Ceva Sante Animale Recent Developments/Updates
6.3 Bimeda Animal Health
6.3.1 Bimeda Animal Health Company Information
6.3.2 Bimeda Animal Health Description and Business Overview
6.3.3 Bimeda Animal Health Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bimeda Animal Health Pet Meds and Supplements Product Portfolio
6.3.5 Bimeda Animal Health Recent Developments/Updates
6.4 Dechra Pharmaceuticals
6.4.1 Dechra Pharmaceuticals Company Information
6.4.2 Dechra Pharmaceuticals Description and Business Overview
6.4.3 Dechra Pharmaceuticals Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Dechra Pharmaceuticals Pet Meds and Supplements Product Portfolio
6.4.5 Dechra Pharmaceuticals Recent Developments/Updates
6.5 Zoetis
6.5.1 Zoetis Company Information
6.5.2 Zoetis Description and Business Overview
6.5.3 Zoetis Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zoetis Pet Meds and Supplements Product Portfolio
6.5.5 Zoetis Recent Developments/Updates
6.6 Merck
6.6.1 Merck Company Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck Pet Meds and Supplements Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Elanco
6.7.1 Elanco Company Information
6.7.2 Elanco Description and Business Overview
6.7.3 Elanco Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Elanco Pet Meds and Supplements Product Portfolio
6.7.5 Elanco Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Company Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bayer Pet Meds and Supplements Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Boehringer
6.9.1 Boehringer Company Information
6.9.2 Boehringer Description and Business Overview
6.9.3 Boehringer Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Boehringer Pet Meds and Supplements Product Portfolio
6.9.5 Boehringer Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Pet Meds and Supplements Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Virbac
6.11.1 Virbac Company Information
6.11.2 Virbac Description and Business Overview
6.11.3 Virbac Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Virbac Pet Meds and Supplements Product Portfolio
6.11.5 Virbac Recent Developments/Updates
6.12 Ceva
6.12.1 Ceva Company Information
6.12.2 Ceva Description and Business Overview
6.12.3 Ceva Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Ceva Pet Meds and Supplements Product Portfolio
6.12.5 Ceva Recent Developments/Updates
6.13 Vetoquinol
6.13.1 Vetoquinol Company Information
6.13.2 Vetoquinol Description and Business Overview
6.13.3 Vetoquinol Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Vetoquinol Pet Meds and Supplements Product Portfolio
6.13.5 Vetoquinol Recent Developments/Updates
6.14 Nexvet
6.14.1 Nexvet Company Information
6.14.2 Nexvet Description and Business Overview
6.14.3 Nexvet Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Nexvet Pet Meds and Supplements Product Portfolio
6.14.5 Nexvet Recent Developments/Updates
6.15 Aratana Therapeutics
6.15.1 Aratana Therapeutics Company Information
6.15.2 Aratana Therapeutics Description and Business Overview
6.15.3 Aratana Therapeutics Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Aratana Therapeutics Pet Meds and Supplements Product Portfolio
6.15.5 Aratana Therapeutics Recent Developments/Updates
6.16 Kindred Biosciences
6.16.1 Kindred Biosciences Company Information
6.16.2 Kindred Biosciences Description and Business Overview
6.16.3 Kindred Biosciences Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Kindred Biosciences Pet Meds and Supplements Product Portfolio
6.16.5 Kindred Biosciences Recent Developments/Updates
6.17 Ambrx
6.17.1 Ambrx Company Information
6.17.2 Ambrx Description and Business Overview
6.17.3 Ambrx Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Ambrx Pet Meds and Supplements Product Portfolio
6.17.5 Ambrx Recent Developments/Updates
6.18 Entest Biomedical
6.18.1 Entest Biomedical Company Information
6.18.2 Entest Biomedical Description and Business Overview
6.18.3 Entest Biomedical Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Entest Biomedical Pet Meds and Supplements Product Portfolio
6.18.5 Entest Biomedical Recent Developments/Updates
6.19 Taconic Biosciences
6.19.1 Taconic Biosciences Company Information
6.19.2 Taconic Biosciences Description and Business Overview
6.19.3 Taconic Biosciences Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Taconic Biosciences Pet Meds and Supplements Product Portfolio
6.19.5 Taconic Biosciences Recent Developments/Updates
6.20 Dechra Veterinary Products
6.20.1 Dechra Veterinary Products Company Information
6.20.2 Dechra Veterinary Products Description and Business Overview
6.20.3 Dechra Veterinary Products Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Dechra Veterinary Products Pet Meds and Supplements Product Portfolio
6.20.5 Dechra Veterinary Products Recent Developments/Updates
6.21 Ouro Fino Saude
6.21.1 Ouro Fino Saude Company Information
6.21.2 Ouro Fino Saude Description and Business Overview
6.21.3 Ouro Fino Saude Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Ouro Fino Saude Pet Meds and Supplements Product Portfolio
6.21.5 Ouro Fino Saude Recent Developments/Updates
6.22 Norbrook
6.22.1 Norbrook Company Information
6.22.2 Norbrook Description and Business Overview
6.22.3 Norbrook Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Norbrook Pet Meds and Supplements Product Portfolio
6.22.5 Norbrook Recent Developments/Updates
6.23 Frontline
6.23.1 Frontline Company Information
6.23.2 Frontline Description and Business Overview
6.23.3 Frontline Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Frontline Pet Meds and Supplements Product Portfolio
6.23.5 Frontline Recent Developments/Updates
6.24 Zesty Paws
6.24.1 Zesty Paws Company Information
6.24.2 Zesty Paws Description and Business Overview
6.24.3 Zesty Paws Pet Meds and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Zesty Paws Pet Meds and Supplements Product Portfolio
6.24.5 Zesty Paws Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Meds and Supplements Industry Chain Analysis
7.2 Pet Meds and Supplements Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Meds and Supplements Production Mode & Process Analysis
7.4 Pet Meds and Supplements Sales and Marketing
7.4.1 Pet Meds and Supplements Sales Channels
7.4.2 Pet Meds and Supplements Distributors
7.5 Pet Meds and Supplements Customer Analysis
8 Pet Meds and Supplements Market Dynamics
8.1 Pet Meds and Supplements Industry Trends
8.2 Pet Meds and Supplements Market Drivers
8.3 Pet Meds and Supplements Market Challenges
8.4 Pet Meds and Supplements Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Boehringer Ingelheim
Ceva Sante Animale
Bimeda Animal Health
Dechra Pharmaceuticals
Zoetis
Merck
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences
Ambrx
Entest Biomedical
Taconic Biosciences
Dechra Veterinary Products
Ouro Fino Saude
Norbrook
Frontline
Zesty Paws
听
听
*If Applicable.